Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC is listed as the manufacturer on 8 FDA drug label records covering 8 distinct active ingredients predominantly human prescription drug products.
About Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC is named as the labeler on 8 FDA drug label records. Its catalogue spans 8 distinct active ingredients, led by ALIROCUMAB, DUPILUMAB, ENOXAPARIN SODIUM, IRBESARTAN. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: treatment adult, pediatric patients, blood pressure, multiple myeloma, myocardial infarction, rifadin infusion, aged years, dupixent indicated. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
| Active ingredient | Products |
|---|---|
| ALIROCUMAB | 1 |
| DUPILUMAB | 1 |
| ENOXAPARIN SODIUM | 1 |
| IRBESARTAN | 1 |
| ISATUXIMAB | 1 |
| ISATUXIMAB-IRFC | 1 |
| RASBURICASE | 1 |
| RIFAMPICIN | 1 |
Dosage forms and routes
| Dosage form | Products | Route | Products |
|---|---|---|---|
| — | — | SUBCUTANEOUS | 4 |
| — | — | INTRAVENOUS | 1 |
| — | — | ORAL | 1 |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
FDA drug products from Sanofi-Aventis U.S. LLC
| Brand name | Generic | Type | Route |
|---|---|---|---|
| Avapro | IRBESARTAN | HUMAN PRESCRIPTION DRUG | ORAL |
| Dupixent | DUPILUMAB | HUMAN PRESCRIPTION DRUG | SUBCUTANEOUS |
| Elitek | RASBURICASE | HUMAN PRESCRIPTION DRUG | |
| Lovenox | ENOXAPARIN SODIUM | HUMAN PRESCRIPTION DRUG | SUBCUTANEOUS |
| Praluent | ALIROCUMAB | HUMAN PRESCRIPTION DRUG | SUBCUTANEOUS |
| Rifadin | RIFAMPICIN | HUMAN PRESCRIPTION DRUG | |
| Sarclisa | ISATUXIMAB | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| Sarclisa Escena | ISATUXIMAB-IRFC | HUMAN PRESCRIPTION DRUG | SUBCUTANEOUS |
Frequently asked questions
How many FDA drug products does Sanofi-Aventis U.S. LLC make?
8 FDA drug label records name Sanofi-Aventis U.S. LLC as the manufacturer, covering 8 distinct active ingredients.
What active ingredients does Sanofi-Aventis U.S. LLC produce?
The most frequent active ingredients in this portfolio are ALIROCUMAB, DUPILUMAB, ENOXAPARIN SODIUM, IRBESARTAN, ISATUXIMAB.
Are Sanofi-Aventis U.S. LLC products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.